Regulation of the MID1 protein function is fine-tuned by a complex pattern of alternative splicing
暂无分享,去创建一个
Andreas Kulozik | Marie-Laure Yaspo | Rainer Schneider | M. Yaspo | V. Kalscheuer | Z. Kijas | A. Kulozik | S. Schweiger | J. Winter | S. Krauß | J. Foerster | Susann Schweiger | Jennifer Winter | Tanja Lehmann | Sybille Krauß | Alexander Trockenbacher | Zofia Kijas | John Foerster | Vanessa Suckow | Vera Kalscheuer | R. Schneider | A. Trockenbacher | V. Suckow | T. Lehmann | Tanja Lehmann | Vanessa Suckow
[1] J. Opitz,et al. Duplication of the MID1 first exon in a patient with Opitz G/BBB syndrome , 2003, Human Genetics.
[2] E. Schuetz,et al. Nonsense mediated decay downregulates conserved alternatively spliced ABCC4 transcripts bearing nonsense codons. , 2003, Human molecular genetics.
[3] S. Brenner,et al. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[4] J. Landry,et al. Widely spaced alternative promoters, conserved between human and rodent, control expression of the Opitz syndrome gene MID1. , 2002, Genomics.
[5] Christopher J. Lee,et al. A genomic view of alternative splicing , 2002, Nature Genetics.
[6] H. Ropers,et al. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation , 2001, Nature Genetics.
[7] Mathew W. Wright,et al. The HUGO Gene Nomenclature Committee (HGNC) , 2001, Human Genetics.
[8] S. Peltz,et al. Nonsense-mediated mRNA decay in Saccharomyces cerevisiae. , 2001, Gene.
[9] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[10] Michael R. Green,et al. Expressing the human genome , 2001, Nature.
[11] J. Lykke-Andersen,et al. mRNA quality control: Marking the message for life or death , 2001, Current Biology.
[12] E. Haan,et al. New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome. , 2000, Human molecular genetics.
[13] A. Ballabio,et al. MID2, a homologue of the Opitz syndrome gene MID1: similarities in subcellular localization and differences in expression during development. , 1999, Human molecular genetics.
[14] A. Ballabio,et al. Functional characterization of the Opitz syndrome gene product (midin): evidence for homodimerization and association with microtubules throughout the cell cycle. , 1999, Human molecular genetics.
[15] G. M. Wilson,et al. Regulation of AUF1 Expression via Conserved Alternatively Spliced Elements in the 3′ Untranslated Region , 1999, Molecular and Cellular Biology.
[16] Yves,et al. The Opitz syndrome gene product, MID1, associates with microtubules. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Hentze,et al. A Perfect Message RNA Surveillance and Nonsense-Mediated Decay , 1999, Cell.
[18] H. Zoghbi,et al. Characterization and physical mapping in human and mouse of a novel RING finger gene in Xp22. , 1998, Genomics.
[19] C. Disteche,et al. The mouse Mid1 gene: implications for the pathogenesis of Opitz syndrome and the evolution of the mammalian pseudoautosomal region. , 1998, Human molecular genetics.
[20] S. Schweiger,et al. A rapid and inexpensive method for large-scale DNA sequencing of regions with large amounts of repetitive elements , 1998 .
[21] George J. Feldman,et al. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22 , 1997, Nature Genetics.
[22] P. Artymiuk,et al. The aconitase family: three structural variations on a common theme. , 1997, Trends in biochemical sciences.
[23] J. Opitz,et al. Opitz G/BBB syndrome: clinical comparisons of families linked to Xp22 and 22q, and a review of the literature. , 1996, American journal of medical genetics.
[24] S. Fields,et al. The two-hybrid system: an assay for protein-protein interactions. , 1994, Trends in genetics : TIG.